Canals-Gispert Lidia, Cañas-Martínez Alba, Huesa Gema, Suárez-Calvet Alomà Marc, Milà-Alomà Marta, Arenaza-Urquijo Eider, Cirillo Davide, Dimech Annemarie Schumacher, Iulita Maria Florencia, Martinkova Julie Novakova, Tartaglia Maria Carmela, Quevenco Frances-Catherine, Chadha Antonella Santuccione, Sánchez-Benavides Gonzalo, Minguillón Carolina, Ferretti Maria Teresa, Fauria Karine, Brugulat-Serrat Anna
Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Alzheimers Res Ther. 2024 Dec 19;16(1):263. doi: 10.1186/s13195-024-01626-1.
Although there is growing evidence of the association between gender and early diagnosis of preclinical Alzheimer's disease, little attention has been given to the enrolment ratio of men and women in clinical trials and data reporting.
This study aims to analyze gender differences in sociodemographic factors associated with the willingness to participate in clinical trials and undergo specific procedures in the context of an Alzheimer's disease prevention research cohort. 2544 cognitively unimpaired participants from the ALFA parent cohort (age 45-75 years) of the Barcelonaβeta Brain Research Center were contacted through a structured phone call to determine their willingness to participate in Alzheimer's disease clinical trials and undergo trial-related procedures (magnetic resonance imaging, lumbar puncture, positron emission tomography, and cognitive assessment). Sociodemographic data on education, occupational attainment, civil and caregiver status were gathered. Stepwise logistic regression models were performed in order to study the interaction between gender and sociodemographic factors in the willingness to participate in clinical trials and to undergo clinical trial-related procedures.
1,606 out of the 2,544 participants were women (63.1%). Women were significantly younger and had lower educational attainment compared with men. In addition, women were more likely to be caregivers, single and unemployed. Women showed a significantly lower willingness than men to participate in a clinical trial (p = 0.003) and to undergo a lumbar puncture (p < 0.001). Single women were less willing to participate in clinical trials than single men (p = 0.041). Regarding clinical trial-related procedures, women with higher years of education were significantly less willing to undergo a lumbar puncture (p = 0.031).
We found gender differences regarding the sociodemographic factors that predict the willingness to participate in clinical trials and to undergo clinical trial-related procedures. Our results highlight the urgent need to design recruitment strategies accounting for gender-related factors, particularly those related to marital status and education.
尽管越来越多的证据表明性别与临床前阿尔茨海默病的早期诊断之间存在关联,但临床试验中的男女入组率和数据报告却很少受到关注。
本研究旨在分析巴塞罗那β脑研究中心阿尔茨海默病预防研究队列中,与参与临床试验意愿及接受特定检查相关的社会人口学因素中的性别差异。通过结构化电话访谈联系了来自巴塞罗那β脑研究中心ALFA母队列(年龄45 - 75岁)的2544名认知功能未受损的参与者,以确定他们参与阿尔茨海默病临床试验及接受与试验相关检查(磁共振成像、腰椎穿刺、正电子发射断层扫描和认知评估)的意愿。收集了关于教育程度、职业成就、婚姻和照料者状况的社会人口学数据。进行逐步逻辑回归模型分析,以研究性别与社会人口学因素在参与临床试验意愿及接受与临床试验相关检查方面的相互作用。
2544名参与者中有1606名女性(63.1%)。与男性相比,女性明显更年轻,受教育程度更低。此外,女性更有可能是照料者、单身且失业。女性参与临床试验的意愿(p = 0.003)和接受腰椎穿刺的意愿(p < 0.001)明显低于男性。单身女性参与临床试验的意愿低于单身男性(p = 0.041)。关于与临床试验相关的检查,受教育年限较长的女性接受腰椎穿刺的意愿明显较低(p = 0.031)。
我们发现,在预测参与临床试验意愿及接受与临床试验相关检查的社会人口学因素方面存在性别差异。我们的结果凸显了迫切需要设计考虑性别相关因素,特别是与婚姻状况和教育相关因素的招募策略。